Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Scalp cooling effectively reduces hair loss from chemotherapy.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

New treatments for hair loss are being developed using molecular biology.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Some medications can cause hair loss, and it's important to track when the hair loss starts after taking a new medication.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.